Fas/Fas ligand interactions promote activation-induced cell death of NK T lymphocytes

被引:94
|
作者
Leite-De-Moraes, MC
Herbelin, A
Gouarin, C
Koezuka, Y
Schneider, E
Dy, M
机构
[1] Univ Paris 05, CNRS, Unite Mixte Rech 8603, Hop Necker, F-75743 Paris 15, France
[2] INSERM, Unite 25, Paris, France
[3] Hop Necker Enfants Malad, Assoc Claude Bernard, Paris, France
[4] Kirin Brewery Co Ltd, Pharmaceut Res Lab, Gunma, Japan
来源
JOURNAL OF IMMUNOLOGY | 2000年 / 165卷 / 08期
关键词
D O I
10.4049/jimmunol.165.8.4367
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
NKT cells are a versatile population whose immunoregulatory functions are modulated by their microenvironment. We demonstrate herein that in addition to their IFN-gamma, production, NKT lymphocytes stimulated with IL-12 plus IL-18 in vitro underwent activation in terms of CD69 expression, blast transformation, and proliferation. Yet they were unable to survive in culture because, once activated, they were rapidly eliminated by apoptosis, even in the presence of their survival factor IL-7. This process was preceded by up-regulation of Pas (CD95) and Pas ligand expression in response to IL-12 plus IL-18 and was blocked by zVAD, a large spectrum caspase inhibitor, as well as by anti-Pas ligand mAb, suggesting the involvement of the Pas pathway, In accordance with this idea, NKT cells from Fas-deficient C57BL/6-lpr/lpr mice did not die in these conditions, although they shared the same features of cell activation as their wild-type counterpart. Activation-induced cell death occurred also after TCR engagement in vivo, since NKT cells became apoptotic after injection of their cognate ligand, alpha-galactosylceramide, in wild-type, but not in Fas-deficient, mice. Taken together, our data provide the first evidence for a ne cv Pas-dependent mechanism allowing the elimination of TCR-dependent or -independent activated NKT cells, which are potentially dangerous to the organism.
引用
收藏
页码:4367 / 4371
页数:5
相关论文
共 50 条
  • [41] Activation-induced cell death in B lymphocytes
    Donjerkovic, D
    Scott, DW
    CELL RESEARCH, 2000, 10 (03) : 179 - 192
  • [42] Activation-induced cell death in B lymphocytes
    DONJERKOVIC DUBRAVKA
    Cell Research, 2000, (03) : 179 - 192
  • [43] Activation-induced cell death of human T-cell subsets is mediated by Fas and granzyme B but is independent of TNF-α
    Gorak-Stolinska, P
    Truman, JP
    Kemeny, DM
    Noble, A
    JOURNAL OF LEUKOCYTE BIOLOGY, 2001, 70 (05) : 756 - 766
  • [44] Proteasome inhibitors block Ras/ERK signaling pathway resulting in the downregulation of fas ligand expression during activation-induced cell death in T cells
    Tanimoto, Y
    Kizaki, H
    JOURNAL OF BIOCHEMISTRY, 2002, 131 (03): : 319 - 326
  • [45] Activation-induced T cell death
    Walczak, H
    Dhein, J
    Peter, ME
    Krammer, PH
    CELL DEATH AND DIFFERENTIATION, 1996, 3 (02): : 245 - 245
  • [46] Role of Fas ligand in T cell activation: Protein-protein interactions.
    Vaishnaw, AK
    Chu, JL
    Raman, C
    Elkon, KB
    ARTHRITIS AND RHEUMATISM, 1996, 39 (09): : 1695 - 1695
  • [47] DIFFERENTIAL ABILITY OF T(H)1 AND T(H)2 T-CELLS TO EXPRESS FAS LIGAND AND TO UNDERGO ACTIVATION-INDUCED CELL
    RAMSDELL, F
    SEAMAN, MS
    MILLER, RE
    PICHA, KS
    KENNEDY, MK
    LYNCH, DH
    INTERNATIONAL IMMUNOLOGY, 1994, 6 (10) : 1545 - 1553
  • [48] Regulation of cell surface expression of Fas (CD95) ligand and susceptibility to Fas (CD95)-mediated apoptosis in activation-induced T cell death involves calcineurin and protein kinase C, respectively
    Tóth, R
    Szegezdi, É
    Molnár, G
    Lord, JM
    Fésüs, L
    Szondy, Z
    EUROPEAN JOURNAL OF IMMUNOLOGY, 1999, 29 (02) : 383 - 393
  • [49] CD8+ tumor-infiltrating lymphocytes are primed for Fas-mediated activation-induced cell death but are not apoptotic in situ
    Radoja, S
    Saio, M
    Frey, AB
    JOURNAL OF IMMUNOLOGY, 2001, 166 (10): : 6074 - 6083
  • [50] Apoptosis of epitope-specific antiretroviral cytotoxic T lymphocytes via fas ligand-fas interactions
    Rich, Robert F.
    Green, William R.
    VIRAL IMMUNOLOGY, 2006, 19 (03) : 424 - 433